0001193125-16-452442.txt : 20160205 0001193125-16-452442.hdr.sgml : 20160205 20160205170600 ACCESSION NUMBER: 0001193125-16-452442 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20160205 DATE AS OF CHANGE: 20160205 EFFECTIVENESS DATE: 20160205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Unilife Corp CENTRAL INDEX KEY: 0001476170 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 271049354 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34540 FILM NUMBER: 161393048 BUSINESS ADDRESS: STREET 1: 250 CROSS FARM LANE CITY: YORK STATE: PA ZIP: 17406 BUSINESS PHONE: (717) 384-3400 MAIL ADDRESS: STREET 1: 250 CROSS FARM LANE CITY: YORK STATE: PA ZIP: 17406 DEFA14A 1 d120508ddefa14a.htm DEFA14A DEFA14A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Filed by the Registrant  x                              Filed by a Party other than the Registrant  ¨

Check the appropriate box:

 

¨   Preliminary Proxy Statement
¨   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨   Definitive Proxy Statement
x   Definitive Additional Materials
¨   Soliciting Material Pursuant to §240.14a-12

UNILIFE CORPORATION

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

x   No fee required.
¨   Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

¨   Fee paid previously with preliminary materials.
¨   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 


LOGO

On February 4, 2016, the Board of Directors (the “Board”) of Unilife Corporation (the “Company”) determined to cancel the special meeting of the Company’s stockholders that was scheduled to be held on Monday, February 8, 2016, at 4:00 P.M. U.S. Eastern Time, at the Crowne Plaza Philadelphia Hotel – King Of Prussia, 260 Mall Blvd., King of Prussia, Pennsylvania 19406 (the “Special Meeting”).

In order to comply with NASDAQ Marketplace Rule 5635(d), the Special Meeting was being held to approve the potential issuance of 20% or more of the Company’s outstanding common stock upon the redemption or conversion of, payment of dividends on and conversion premium on the 790 shares of the Company’s Series A Redeemable Convertible Preferred Stock (collectively, the “Preferred Shares”) that the Company issued to an institutional investor (the “Fund”) pursuant to that certain Stock Purchase Agreement, dated November 9, 2015, by and between the Company and the Fund (the “Purchase Agreement”).

The Company no longer has any Preferred Shares outstanding. As previously disclosed, on February 3, 2016, the Company entered into that certain First Amendment to the Purchase Agreement, pursuant to which the Company agreed to issue to the Fund 8,316,678 shares of the Company’s common stock (collectively, the “Shares”), which amount, when aggregated with the shares of the Company’s common stock that the Company had previously issued to the Fund in connection with the Purchase Agreement, represent less than 20% of the Company’s outstanding common stock. The Fund has converted the 790 Preferred Shares into shares of the Company’s common stock and is no longer the holder of any Preferred Shares and, upon the timely delivery of the Shares, the Company will have no further obligations to the Fund with respect to any of the Preferred Shares. Since the Company will not be issuing 20% or more of its outstanding common stock to the Fund stockholder approval is no longer required, and the Board determined to cancel the Special Meeting.

 

2

GRAPHIC 2 g120508snap1.jpg GRAPHIC begin 644 g120508snap1.jpg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